Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients

View source ↗

Summary

This completed observational study evaluated the safety and efficacy of ATG-F in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• ATG-F (anti-thymocyte globulin fragment F)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Kidney Transplant Recipients | Status: COMPLETED